Answers are grounded in this paper and cite their sources.
Investigate efficacy and safety of sodium–glucose cotransporter 2 inhibitors (SGLT2i) as well as glucagon-like peptide 1 receptor (GLP-1RA) and peroxisome proliferator-activated receptor-γ agonists (PPAR-γ) on stroke prevention.
No takes yet. Share an insight, caveat, or question.
Barry et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: